language English
Article 2021 · 34 atıf

Protective effects of gallic acid on doxorubicin-induced cardiotoxicity; an experimantal study

Akdemir, Fazile Nur Ekinci, Yildirim, Serkan, Kandemir, Fatih Mehmet, Tanyeli, Ayhan, Kucukler, Sefa, Dortbudak, Muhammed Bahaeddin

Özet

The present study aims to examine the possible beneficial effects of gallic acid (GA) against doxorubicin-induced cardiotoxicity in the experimental model. Rats were weighed and divided into groups. Groups as following; control, gallic acid (GA), doxorubicin (DOX) and GA + DOX groups. At the end of the experiment, rats were sacrificed and heart tissue removed. The tissues were analysed in terms of biochemical (MDA, SOD, CAT, GSH, GPx), pathological (hyaline degeneration, Zenkerin necrosis, hyperaemia) and immunohistochemical (TNF-alpha, Cox-2). MDA level decreased and antioxidant enzyme activities increased in GA + DOX group compared to doxorubicin group. TNF-alpha, Cox-2 expression levels were severe in the DOX group. Also, pathologic tissue damage in heart tissue increased due to doxorubicin. Additionally, pathologic tissue damage and TNF-alpha, Cox-2 expression levels decreased in GA + DOX group. According to our findings, GA has protective effect against doxorubicin-induced cardiotoxicity.

Anahtar Kelimeler
Doxorubicin gallic acid cardiotoxicity antioxidant cytokins rat ADRIAMYCIN-INDUCED CARDIOMYOPATHY OXIDATIVE STRESS INDUCED APOPTOSIS LIVER-DAMAGE TNF-ALPHA CYCLOOXYGENASE-2 ANTIOXIDANTS INHIBITION DIOSCIN INJURY
WoS Kategorileri
Biochemistry & Molecular Biology Biophysics Endocrinology & Metabolism Physiology
Sürdürülebilir Kalkınma Amaçları
Künye
Dergi
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Yıl
2021
Cilt
127
Sayı
3
Sayfa
258-265
ISSN
1381-3455
eISSN
1744-4160
DOI
10.1080/13813455.2019.1630652
WoS UID
WOS:000475144500001
Yayını aç (DOI)